Related Experiment Videos
Total excision and extra-anatomic bypass for aortic graft infection
J J Ricotta1, G L Faggioli, A Stella
1Department of Surgery, Millard Fillmore Hospitals, Buffalo, New York 14209.
American Journal of Surgery
|August 1, 1991
Summary
Total excision with extra-anatomic bypass for aortic graft infection offers lower morbidity and mortality. This standard approach avoids late complications like amputation, proving superior to alternative treatments.
Area of Science:
- Vascular Surgery
- Infectious Disease Management
Background:
- Aortic graft infection presents significant challenges with high reported mortality and amputation rates.
- Alternative treatments like local antibiotics and partial resection have been explored due to concerns about traditional methods.
Purpose of the Study:
- To review experience with aortic graft infection to determine current morbidity and mortality rates.
- To evaluate the efficacy of total excision and extra-anatomic bypass compared to other approaches.
Main Methods:
- Retrospective review of 32 patients with aortic graft infection.
- Analysis of treatment strategies including partial or total removal with or without revascularization (extra-anatomic route).
- Comparison of outcomes based on treatment modality, focusing on morbidity, mortality, and late complications.
Main Results:
- Overall morbidity and mortality were significantly lower in revascularized groups (p = 0.01).
- Late complications, including amputation, were exclusively observed after partial graft removal (p < 0.01).
- Total excision with extra-anatomic bypass demonstrated the best outcomes, with no late infections or amputations in a mean follow-up of 34 months.
Conclusions:
- Total excision and extra-anatomic bypass for aortic graft infection yield lower complication rates than commonly perceived.
- This approach remains the gold standard for managing aortic graft infections, outperforming alternative strategies.
- The study supports continued use of total excision with extra-anatomic bypass as the preferred treatment for aortic graft infections.